Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
BMC Gastroenterology|July 20, 2018
Design of the Weight-loss Endoscopy Trial (WET): a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedureMarcus Hollenbach, Christiane Prettin, Felix Gundling, et al.
Diabetes, Obesity & Metabolism|September 6, 2016
Dyslipidaemia and its treatment in patients with type 2 diabetes: A joint analysis of the German DIVE and DPV registriesPeter Bramlage, Stefanie Lanzinger, Wolfgang Rathmann, et al.
The Lancet. Diabetes & Endocrinology|September 24, 2020
Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trialsJohannes F E Mann, Thomas Hansen, Thomas Idorn, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2019
Reductions in Insulin Resistance are Mediated Primarily via Weight Loss in Subjects With Type 2 Diabetes on SemaglutideVivian A Fonseca, Matthew S Capehorn, Satish K Garg, et al.
Therapeutic Advances in Endocrinology and Metabolism|March 6, 2019
Patient and disease characteristics of adult patients with type 1 diabetes in Germany: an analysis of the DPV and DIVE databasesGesine van Mark, Stefanie Lanzinger, Ralf Barion, et al.
Journal of Gastroenterology|June 10, 2009
Differential effects of PPARgamma activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivoOliver H Al-Taie, Tilmann Graf, Bertram Illert, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 24, 2014
Carbohydrate intake and insulin requirement in children, adolescents and young adults with cystic fibrosis-related diabetes: A multicenter comparison to type 1 diabetesNicole Scheuing, Angelika Thon, Katja Konrad, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2026
68Ga-DOTA-exendin-4 PET/CT for Insulinoma Localization in Patients with Negative or Inconclusive Conventional ImagingJulia G Fricke, Katharina Laubner, Manuela Schildmeijer, et al.
Advances in Therapy|May 24, 2019
Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE RegistriesGesine van Mark, Stefanie Lanzinger, Stefan Sziegoleit, et al.
Diabetes, Obesity & Metabolism|October 25, 2019
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT studyAlice Cheng, Stewart Harris, Francesco Giorgino, et al.
Pageof 15